🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,136 results for “The First People's Hospital of Lianyungang” Clear

  1. dexlansoprazole injection

    The First People's Hospital of Lianyungang

    Safety Issues

    phase 1 small molecule completed

    1 trial

  2. domestic polysaccharide superparamagnetic iron oxide nanoparticle

    The First People's Hospital of Lianyungang

    Chronic Kidney Diseases

    phase 1 small molecule completed

    1 trial

  3. fRPE cells

    The First People's Hospital of Lianyungang

    Age Related Macular Degeneration

    phase 1 small molecule active

    1 trial

  4. hCD19.IL15.CAR-iNKT

    The First People's Hospital of Lianyungang

    Acute Lymphoblastic Leukemia

    phase 1 small molecule active

    1 trial

  5. human HER2-targeted CAR-M cells

    The First People's Hospital of Lianyungang

    Gastric Cancer

    phase 1 mab active

    1 trial

  6. narfurine hydrochloride orally disintegrating tablets

    The First People's Hospital of Lianyungang

    Improvement of Pruritus in Hemodialysis Patients

    phase 1 small molecule active

    1 trial

  7. pd-1 and DC-NK cells

    The First People's Hospital of Lianyungang

    Solid Tumor

    phase 1 small molecule active

    1 trial

  8. pd-1 and dc-cik cells

    The First People's Hospital of Lianyungang

    Solid Tumor

    phase 1 small molecule active

    1 trial

  9. prophylactic 4SCAR19 cells

    The First People's Hospital of Lianyungang

    B Acute Lymphoblastic Leukemia

    phase 1 gene therapy active

    1 trial

  10. salvianolic acid A

    The First People's Hospital of Lianyungang

    Diabetes

    phase 1 small molecule active

    1 trial

  11. salvianolic acid A

    The First People's Hospital of Lianyungang

    Healthy

    phase 1 small molecule active

    1 trial

  12. standard chemotherapy medicine combined with Chinese herbs

    The First People's Hospital of Lianyungang

    Carcinoma, Non-Small-Cell Lung

    phase 1 small molecule active

    1 trial

  13. stem cells

    The First People's Hospital of Lianyungang

    Diminished Ovarian Response

    phase 1 other active

    1 trial

  14. suramin sodium

    The First People's Hospital of Lianyungang

    Hand, Foot and Mouth Disease

    phase 1 small molecule active

    1 trial

  15. triple-branched stent graft

    The First People's Hospital of Lianyungang

    Acute Aortic Dissection

    phase 1 other active

    1 trial

  16. universal CLL1 CAR-T cells

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia

    phase 1 mab active

    1 trial

  17. γδT Cell infusion agent

    The First People's Hospital of Lianyungang

    Leukemia, B-cell

    phase 1 small molecule active

    1 trial

  18. "Nefecon®","Ambrisentan"

    The First People's Hospital of Lianyungang

    IgA Nephropathy

    approved small molecule active

    1 trial

  19. 20mg Febuxostat

    The First People's Hospital of Lianyungang

    Hyperuricemia

    approved small molecule active

    1 trial

  20. 37.5mg Pregabalin + 75mg Pregabalin

    The First People's Hospital of Lianyungang

    Pain, Postoperative

    approved small molecule completed

    1 trial

  21. ALA

    The First People's Hospital of Lianyungang

    Actinic Keratoses

    approved small molecule active

    1 trial

  22. AN69ST hemofilter

    The First People's Hospital of Lianyungang

    Critical Ill Patients

    approved other completed

    1 trial

  23. Aerosolized 13 cis retinoic acid plus Vitamin D

    The First People's Hospital of Lianyungang

    Post COVID-19 Anosmia (Loss of Smell)

    approved small molecule active

    1 trial

  24. Alprostadil

    The First People's Hospital of Lianyungang

    Stroke

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources